Genetic Stability
Embryonic stem cell origin supports consistent cellular identity.
T5004 · Research Use Only
Human Cardiomyocytes
Stop Waiting. Start Beating.
Ready-to-use human embryonic stem cell-derived cardiomyocytes are cryopreserved and functionally validated, with spontaneous contractions typically beginning within 3–5 days after plating.
T5004 provides a reproducible human cardiac model for drug discovery, cardiotoxicity screening, disease modelling, electrophysiology, and advanced 3D cardiac workflows.
Functional recovery
Watch Human Cardiomyocytes Beat
Representative cultures demonstrate spontaneous contractions after plating, with beating typically observed within 3–5 days.
Functional validation
Ready-to-use cardiac cells for time-sensitive workflows
Rapid Recovery
Spontaneous beating typically begins within 3–5 days.
Cardiac Identity
Key contractility markers are characterized by molecular and imaging assays.
Consistency
Controlled differentiation supports repeatable experimental outcomes.
Performance
Functional cardiac behaviour is maintained for roughly 10–14 days in culture.
Applications
Human-relevant cardiac workflows
Drug Discovery
Evaluate efficacy and cardiac responses during preclinical development.
Cardiotoxicity Screening
Identify adverse cardiac effects earlier during compound evaluation.
Disease Modelling
Study cardiac physiology and disease mechanisms in a human cell model.
Electrophysiology & Contractility
Assess beating behaviour, electrical activity, and functional response.
Tissue Engineering & Organoids
Build advanced 3D cardiac models and organoid systems.
Validation Data
Verified cardiac identity and function
T5004 undergoes molecular, phenotypic, and functional characterization to support cardiac lineage identity and performance.
TM213 Differentiation Medium Kit
Generate Functional Cardiomyocytes In-House
For researchers who want control over differentiation, TM213 supports a streamlined workflow for generating cardiomyocytes from human embryonic stem cells.
Maintain Control
Run the differentiation workflow in your own laboratory.
Scale to Your Needs
Generate cells based on project demand.
Reproducible Protocol
Use an optimized workflow designed for consistent differentiation.
Compatible Platform
Integrate with toxicity, disease modelling, and 3D culture workflows.
Promotional Cardiac Research Bundle
T5004 + 3DCelMatrix™ + Maintenance Medium Kit
A bundled cardiac workflow combines ready-to-use cardiomyocytes, extracellular-matrix support, and maintenance medium.
FAQ
Frequently Asked Questions
How quickly do the cardiomyocytes begin beating?
Spontaneous contractions are typically observed within 3–5 days after plating.
What validation is performed?
Cardiac identity is evaluated using molecular markers, immunocytochemistry, electrophysiology, sterility, and post-thaw viability checks.
How long are the cells functionally stable?
Functional performance is typically maintained for approximately 10–14 days in culture.